LeMaitre Vascular DCF Stock Analysis

Here’s my assumptions:

Risk Free Rate (10 Years Interest Rate Swap): 3.76%

Risk Premium (Taken from the Aswath Damodaran equity premium spreadsheet): 4.33%

Interest Rate Spread on The Risk free rate ( For the cost of debt calculation): 3.5%

Historical Data

Revenue growth in the last 10 years (CAGR): 10.98%

Earnings growth in the last 10 years (CAGR): 18.89%

Unlevered Free Cash Flow growth in the last 10 years (CAGR): 12.61%

Future Assumptions

End of Year FCF growth: 6%

Growth until end of 2026: 12%

Growth until end of 2034: 10%

Perpetual growth: 3%

Net Debt: -0.133B

Outstanding Stock Options Present Value Assumption: $0.027B

Restricted Stock Units Present Value Assumption: $0.01B

Stock Valuation based on these assumptions: $78

Last update 09/12/2025

Data source: SEEKING ALPHA

Claim $30 off your first subscription. (This is an affiliate link)

All the content in this newsletter should be taken as informational content only. THIS IS NOT FINANCIAL ADVICE! Do your own Due Diligence before investing or contact a professional financial advisor.

I don’t have a position in LeMaitre Vascular (LMAT) and I don’t plan to add a position in the coming days.